耳鼻咽喉科・頭頸部外科91巻6号

2019年05月発行

特集 細菌感染に立ち向かう—抗菌薬使用の新常識

《細菌感染に関する新たな知見》

腸内細菌に関する最近の話題と糞便微生物移植法

著者： 水野慎大¹ 金井隆典¹

所属機関： ¹慶應義塾大学医学部内科学（消化器）

ページ範囲：P.467 - P.471

文献概要

POINT

●腸内細菌が攪乱されたdysbiosisは全身疾患の発症と関わっている。

●糞便微生物移植法（FMT）はdysbiosisの改善を強力に誘導する治療法である。

●FMTは多数の全身疾患の治療法として期待されている。

●安全面・有効性のいずれにおいてもFMTは発展途上の治療法である。

参考文献

1）Chua HH, et al：Intestinal dysbiosis featuring abundance of ruminococcus gnavus associates with allergic diseases in infants. Gastroenterology 154：154-167, 2018

2）Kiyohara H, et al：Toll-like receptor 7 agonist-induced dermatitis causes severe dextran sulfate sodium colitis by altering the gut microbiome and immune cells. Cell Mol Gastroenterol Hepatol 7：135-156, 2018

3）Eiseman B, et al：Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44：854-859, 1958

4）Van Nood E, et al：Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368：407-415, 2013

5）Lessa FC, et al：Burden of Clostridium difficile infection in the United States. N Engl J Med 372：825-834, 2015

6）Bakken JS, et al：Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 9：1044-1049, 2011

7）Mullish BH, et al：The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications：joint British Society of Gastroenterology（BSG）and Healthcare Infection Society（HIS）guidelines. Gut 67：1920-1941, 2018

8）Mizuno S, et al：Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients. Intest Res 15：68-74, 2017

9）Paramsothy S, et al：Multidonor intensive faecal microbiota transplantation for active ulcerative colitis：a randomised placebo-controlled trial. Lancet 389：1218-1228, 2017

10）Johnsen PH, et al：Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome：a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol 3：17-24, 2018

11）Halkjær SI, et al：Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome：results from a randomised, double-blind placebo-controlled study. Gut 67：2107-2115, 2018

12）Ridaura VK, et al：Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341：1241214, 2013

13）Vrieze A, et al：Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143：913-916, 2012

14）Kang DW, et al：Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms：an open-label study. Microbiome 5：10, 2017

15）Qi X, et al：Treating steroid refractory intestinal acute graft-vs. -host disease with fecal microbiota transplantation：a pilot study. Front Immunol 9：2195, 2018

16）Kao D, et al：Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent clostridium difficile infection：a randomized clinical trial. JAMA 318：1985-1993, 2017

17）Moayyedi P, et al：Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149：102-109, 2015

18）Smillie CS, et al：Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation. Cell Host Microbe 23：229-240, 2018

19）Mizuno S, et al：Bifidobacterium-rich fecal donor may be a positive predictor for successful fecal microbiota transplantation in patients with irritable bowel syndrome. Digestion 96：29-38, 2017

20）Ott SJ, et al：Efficacy of sterile fecal filtrate transfer for treating patients with clostridium difficile infection. Gastroenterology 152：799-811, 2017

21）McDonald JAK, et al：Inhibiting growth of clostridioides difficile by restoring valerate, produced by the intestinal microbiota. Gastroenterology 155：1495-1507, 2018